” When the Ricaurte story was unfolding, MAPS finally acquired FDA indication-off over a protocol for human trials of MDMA as a treatment method for PTSD, but only following it bought a $one million insurance policy plan to indemnify the evaluate board."It is vital to keep in mind that they are not illicit drugs once they're used in exploration,"… Read More